A score based on age, toxic habits, cardiovascular risk factors and ABCB1 C1236T polymorphism, for a population of patients treated with paclitaxel, predicts with specificity the probability of developing chronic chemotherapy-induced peripheral neuropathy. The gene discussed is ABCB1; the disease is peripheral neuropathy.